Opinion
Pharmacies’ future rests on pharmacists
There is a lot of talk in the industry about the role of retail pharmacists and how it will change in response to the aspirations of those professionals; the knowledge and expertise they possess; and the needs of a creaking health care system, notably the problems of patient access and rising expend
People power as valuable as data during holidays
Retailers spend millions of dollars combing through data to help them determine ideal store layouts, merchandise packaging and sales strategies to maximize consumer spending over the holiday season. Real-time data tools promise to give organizations a rapid picture of what’s working and what’s not.
A look into Walgreens and Kroger’s partnership
The recent partnership of Kroger and Walgreens caught many industry experts off guard largely because the agreement goes against conventional wisdom of maximizing competitive advantages.
New technologies: opportunities and challenges
Editor’s note: The second in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. There is no question that science is rapidly accelerating the health care opportunities we see in the marketplace.
Walmart gets ready for what comes next
Despite all the attention that Amazon justifiably receives for the transformational effect it is exerting on mass market retailing, a case can be made that the company that is in the best position to meet the omnichannel needs of consumers over the long term is Walmart.
Drug stores, grocers: the health care edge they have
Pharmacies and grocery stores are better positioned than doctors to promote healthy behavior and prevent debilitating and costly illnesses. Many executives know this, but it is surprising how many acknowledge they have not done much about it.
How to bring about new consumer relationships
To address the personal forms of value that tomorrow’s consumers will demand, consumer packaged goods companies need to move from “idle” to “agile.” Chain drug stores are uniquely positioned to help.
WBA recasts stores, business model
For the better part of a decade, Walgreens Boosts Alliance has been engaged in continually rethinking what a chain drug store means to the consumer, and how the format needs to evolve to remain relevant in an era when digital technology is changing the rules of the game in retailing and health care.
It’s time for nonstop consumer drug take-back
On October 27 the Drug Enforcement Agency (DEA) will hold its 14th National Consumer Drug Take-Back Day. The event will be well publicized and will enable the safe and secure disposal of millions of pounds of expired and unneeded prescription medications.
Our mission remains as relevant as ever
A little over 40 years ago, the first issue of Chain Drug Review appeared.
Donald maintains continuity at Albertsons
The appointment of Jim Donald to succeed Bob Miller as chief executive officer of Albertsons Cos. earlier this month symbolizes the company’s ability to maintain its equilibrium when confronted with adversity and find new ways forward.
Pharmacies need relief from DIR fees
creating greater and greater financial challenges for retail pharmacies. In the second quarter of 2018, DIR accounted for 1.13% of sales and, year-to-date, it is trending at 1% of sales. For the same period last year, DIR was running at 0.9% of sales. On top of
Amazon reigns as premier product search engine
Last month investment firm Piper Jaffray projected Amazon will more than triple its advertising business to some $16 billion by 2021, largely based on the retail giant’s position as “the world’s largest product search engine.
Wealthy and not healthy vs. healthy and not wealthy
those born between 1981 and 1997 — will represent the largest and most influential adult generational cohort in America, with a profound opportunity to realign the nation’s priorities as they enter their prime years and influence the shape of the future health care landscape. Millennials
What to do about mounting transportation costs
The high value of pharmaceutical shipments has traditionally meant that all parties in the chain drug industry were primarily concerned with quality. They needed a reliable, transparent solution. Given that shipping represented a tiny percentage of drug costs, price was a lesser concern.